Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioAge Labs Inc.

    NASDAQ: BIOA · Real-Time Price · USD
    4.37
    -0.15 (-3.32%)
    At close: Jun 16, 2025, 3:59 PM
    4.52
    3.43%
    Pre-market: Jun 17, 2025, 05:59 AM EDT

    BioAge Labs Statistics

    Share Statistics

    BioAge Labs has 35.85M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 35.85M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 64.22%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 980

    FTD / Avg. Volume

    n/a
    		 0.34%

    Short Selling Information

    The latest short interest is 1.58M, so 4.42% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.58M

    Short % of Shares Out

    n/a
    		 4.42%

    Short % of Float

    n/a
    		 5.18%

    Short Ratio (days to cover)

    n/a
    		 8.44

    Valuation Ratios

    The PE ratio is -0.87 and the forward PE ratio is -2. BioAge Labs's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -0.87

    Forward PE

    n/a
    		 -2

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.19

    P/FCF Ratio

    n/a
    		 -1.2

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioAge Labs.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 12.86, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 12.86

    Quick Ratio

    n/a
    		 12.86

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.11

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,146,919.35

    Employee Count

    n/a
    		 62

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.77, so BioAge Labs's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.77

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 4.01

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 57.41

    Average Volume (20 Days)

    n/a
    		 289,944

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -78.19M

    Net Income

    n/a
    		 -71.11M

    EBITDA

    n/a
    		 -78.19M

    EBIT

    n/a
    		 -73.48M

    Earnings Per Share (EPS)

    n/a
    		 -6.63
    Full Income Statement

    Balance Sheet

    The company has 354.35M in cash and 8.7M in debt, giving a net cash position of 345.64M.

    Cash & Cash Equivalents

    n/a
    		 354.35M

    Total Debt

    n/a
    		 8.7M

    Net Cash

    n/a
    		 345.64M

    Retained Earnings

    n/a
    		 -252.81M

    Total Assets

    n/a
    		 343.84M

    Working Capital

    n/a
    		 301.07M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -51.52M and capital expenditures -366K, giving a free cash flow of -51.89M.

    Operating Cash Flow

    n/a
    		 -51.52M

    Capital Expenditures

    n/a
    		 -366K

    Free Cash Flow

    n/a
    		 -51.89M

    FCF Per Share

    n/a
    		 -4.84
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BIOA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BIOA is $5, which is 14.4% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 14.4%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.06

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist